|
시장보고서
상품코드
1481926
유럽의 수의 진단 시장 예측(-2030년) : 지역 분석 - 제품 유형, 기술, 동물 유형, 질환 유형, 최종사용자별Europe Veterinary Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Technology, Animal Type, Disease Type, and End User |
||||||
유럽의 수의 진단 시장은 2022년에 10억 6,437만 달러로 평가되며, 2030년에는 18억 7,497만 달러에 달할 것으로 예측되며, 2022-2030년의 CAGR은 7.3%로 성장할 것으로 예측되고 있습니다.
인수공통 감염증의 유행이 유럽의 수의 진단 시장을 활성화
인수공통전염병은 동물뿐만 아니라 사람에게도 질병을 일으킵니다. 이러한 전염병은 경증부터 중증까지 다양한 증상을 유발합니다. 외교문제협의회(Council on Foreign Relations)에 따르면 인수공통전염병은 매년 전 세계에서 25억 명의 질병과 270만 명의 사망을 유발하며, 알려진 전염병의 60%, 신종 또는 신흥 전염병의 75%를 차지합니다. 또한 질병관리본부에 따르면 2023년에는 인간 감염병 10건 중 6건이 동물에 의해 감염되고, 신종 및 신흥 감염병 4건 중 3건이 동물에 의해 감염될 것으로 예상하고 있습니다. 또한 광견병의 인간 전파의 99%는 개에 의한 것으로, 인간 광견병 사망의 주요 원인으로 꼽히고 있습니다. 개를 통한 광견병으로 인한 경제적 부담은 전 세계에서 연간 86억 달러에 달할 것으로 추정됩니다.
유럽질병예방통제센터에 따르면 캄필로박터증은 2020년 120,946건, 2021년 127,840건으로 가장 많이 보고된 인수공통전염병으로 나타났습니다. 살모넬라증은 두 번째로 많은 인수공통전염병으로 2020년 52,702건, 2021년 60,050건이었습니다. 기타 인수공통전염병으로는 야니병 6,789건, 시가톡신 생성 대장균 감염증 6,084건, 리스테리아증 2,183건 등이 있습니다. 이처럼 전 세계에서 광견병이 증가함에 따라 질병 진단의 필요성이 높아져 수의 진단 시장의 성장에 기여하고 있습니다. 또한 인수공통전염병의 세계적 유행도 수의 진단에 대한 수요를 가속화하고 있습니다.
유럽의 수의 진단 시장 개요
Understanding Animal Research 2023 보고서에 따르면 유럽연합(EU)과 노르웨이에서는 동물이 연구에 널리 이용되고 있습니다. 쥐, 물고기, 쥐, 쥐, 새 등 동물이 사용 동물의 거의 93%를 차지하고, 고양이, 개, 영장류는 0.22%입니다. EU에서 연구용 동물 이용률이 가장 높은 국가는 독일로, 2019년 EU에서 연구에 사용된 동물은 총 11,609,978마리이며, 그 중 실험 목적으로 사용된 동물은 10,40,1673마리(90%)입니다. 11,609,978마리 중 10%(즉, 1,208,305마리)가 유전자 변형 동물 생산에 사용되었으며, Understanding Animal Research 2023 보고서에 따르면 2018년 대비 동물의 질병 중증도 2018년 대비 이용된 동물은 4% 미만이었습니다. 따라서 동물 연구에 대한 수요가 증가함에 따라 수의학 동물 진단 테스트의 필요성이 대두되고 있습니다. 세계보건기구(WHO)는 2020년에 H5N1 조류독감 바이러스의 거위/광둥계통이 조류의 발병을 일으켰다고 보고했습니다. 또한 2020년 이후 H5 2.3.4.4.4b에 속하는 이 바이러스 변종으로 인해 많은 유럽 국가에서 야생 조류와 가금류에서 전례 없는 사망자가 발생했습니다. 또한 EU 역내 동물과 동물의 거래가 증가함에 따라 질병이 역내로 확산되고 있습니다. 따라서 동물로부터의 질병 발생을 극복하는 것은 시대적 요청입니다. 그 결과, 영국은 EU 전역에서 가축의 높은 복지 기준을 추진하고 있습니다. 또한 영국은 과학적 검사에 사용되는 동물의 일반적인 건강 상태를 개선하는 등의 조치를 성공적으로 시행하고 있습니다.
유럽 수의 진단 시장 매출 및 2030년까지의 예측(금액)
유럽의 수의 진단 시장 세분화
유럽 수의 진단 시장은 제품, 기술, 질병 유형, 동물 유형, 최종사용자, 국가별로 분류됩니다.
제품별로 유럽 수의 진단 시장은 기기와 소모품으로 나뉘며, 2022년에는 기기 부문이 큰 비중을 차지할 것으로 예상됩니다.
기술별로 유럽 수의 진단 시장은 면역진단, 임상 생화학, 혈액학, 분자진단, 기타 수의 진단 기술로 구분되며, 2022년에는 면역진단학 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다. 면역진단학 부문은 다시 측면 흐름 분석, ELISA, 면역 분석, 알레르겐 특이적 면역진단학 검사, 기타 면역진단학으로 세분화됩니다. 임상 생화학 분야는 임상 화학 분석, 포도당 모니터링, 혈액가스 및 전해질로 세분화됩니다.
질병 유형별로 유럽 수의 진단 시장은 감염성 질환과 비감염성 질환으로 구분되며, 2022년에는 감염성 질환 분야가 가장 큰 점유율을 차지할 것으로 예상됩니다.
동물 유형별로 유럽 수의 진단 시장은 가축과 반려동물로 양분되며, 2022년에는 반려동물 부문이 더 큰 점유율을 차지할 것으로 예상됩니다. 가축 부문은 소, 돼지, 가금류 및 기타 가축으로 세분화됩니다. 반려동물 부문은 개, 고양이, 말, 기타 반려동물로 세분화됩니다.
최종사용자별로 유럽 수의 진단 시장은 동물병원 및 진료소, 동물 진단 실험실, 수의학 연구기관 및 대학으로 구분되며, 2022년에는 반려동물 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다.
국가별로 유럽 수의 진단 시장은 독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽으로 구분됩니다. 독일이 2022년 유럽 수의 진단 시장을 독점합니다.
FUJIFILM Holdings Corp, Heska Corp, Indexx Laboratories Inc, INDICAL BIOSCIENCE GmbH, Merck Animal Health, Neogen Corp, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac SA, Zoetis Inc 등이 유럽 수의 진단 시장에서 활동하는 주요 기업입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
- 유럽의 수의 진단 시장, 국가별
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 유럽의 수의 진단 시장 - 주요 산업 역학
- 시장 촉진요인
- 인수공통 감염증의 유행 증가
- 반려동물 사육수의 증가
- 주요 시장 억제요인
- 수의학 연구에서 숙련 전문가의 부족
- 주요 시장 기회
- 수의 진단에서 기술의 진보
- 향후 동향
- 수의 진단에서 정밀의료의 등장
제5장 수의 진단 시장 - 유럽 시장 분석
- 유럽의 수의 진단 시장 매출, 2022-2030년
제6장 유럽의 수의 진단 시장 - 매출과 2030년까지의 예측 : 제품별
- 시장 매출 점유율, 2022년 및 2030년
- 기구
- 소모품
제7장 유럽의 수의 진단 시장 - 매출과 2030년까지의 예측 : 기술별
- 시장 매출 점유율, 2022년 및 2030년
- 면역진단학
- 임상 생화학
- 혈액학
- 분자진단학
- 기타 수의 진단 기술
제8장 유럽의 수의 진단 시장 - 매출과 2030년까지의 예측 : 동물 유형별
- 시장 매출 점유율, 2022년 및 2030년
- 축산 동물
- 반려동물
제9장 유럽의 수의 진단 시장 - 매출과 2030년까지의 예측 : 질환 유형별
- 시장 매출 점유율, 2022년 및 2030년
- 감염증
- 비감염성 질환
제10장 유럽의 수의 진단 시장 - 매출과 2030년까지의 예측 : 최종사용자별
- 시장 매출 점유율, 2022년 및 2030년
- 동물병원·진료소
- 동물 진단 연구소
- 수의학 연구기관·대학
제11장 유럽의 수의 진단 시장 - 매출과 2030년까지의 예측 : 국가별 분석
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타
제12장 업계 상황
- 시장 참여 기업의 성장 전략(%)
- 유기적 개발
- 무기적 개발
제13장 기업 개요
- Thermo Fisher Scientific Inc
- Idexx Laboratories Inc
- Zoetis Inc
- Heska Corp
- Neogen Corp
- Randox Laboratories Ltd
- Virbac SA
- INDICAL BIOSCIENCE GmbH
- FUJIFILM Holdings Corp
- Merck Animal Health
제14장 부록
KSA 24.05.31The Europe veterinary diagnostics market was valued at US$ 1,064.37 million in 2022 and is expected to reach US$ 1,874.97 million by 2030; it is estimated to grow at a CAGR of 7.3% from 2022 to 2030.
Rising Prevalence of Zoonotic Disease Fuels Europe Veterinary Diagnostics Market
Zoonotic diseases cause illnesses not only in animals but also in humans. These infections can cause from mild to severe conditions. As per the Council on Foreign Relations, zoonoses cause 2.5 billion illnesses and 2.7 million deaths each year globally, accounting for 60% of known infectious diseases and 75% of new or emerging infectious diseases. Also, according to Centers for Disease Control and Prevention, in 2023, 6 out of every 10 infectious diseases in humans are spread by animals, and 3 of 4 new or emerging infectious diseases are transferred by animals. Further, dogs contribute to 99% of all rabies transmissions to humans and are a major source of human rabies deaths. The economic burden due to dog-mediated rabies is estimated to be US$ 8.6 billion/year globally.
According to the European Centre for Disease Prevention and Control, campylobacteriosis was the most reported zoonotic disease, with 127,840 cases in 2021 compared to 120,946 cases in 2020. Salmonellosis was the second most common zoonotic disease, with 60,050 cases in 2021 compared to 52,702 cases in 2020. The other commonly reported zoonotic diseases are Yarniniosis with 6,789 cases, Shigatoxin-producing E. coli infections with 6,084 cases, and listeriosis with 2,183 cases. Thus, the rising rabies globally increases the need for diagnoses of the illnesses, contributing to the growth of the veterinary diagnostics market. Also, the rising prevalence of zoonotic diseases globally accelerates the demand for veterinary diagnostics.
Europe Veterinary Diagnostics Market Overview
As per the Understanding Animal Research 2023 report, animals have been widely used for research in the European Union (EU) and Norway. Animals such as mice, fish, rats, and birds account for almost 93% of the animals used, with cats, dogs, and primates accounting for 0.22%. Among the EU, Germany has the highest utility of animals for research. A total of 11,609,978 animals were used for research in the EU in 2019, among which 10,40,1673 animals (90%) were used for experimental purposes. Among 11,609,978, 10% (i.e., 1,208,305 animals) were utilized for producing genetically altered animals. As per the Understanding Animal Research 2023 report, less than 4% animals were utilized as compared to 2018 due to the high severity of diseases among animals. Therefore, the rising need for animal research propels the need for diagnostic testing of veterinary animals. The World Health Organization (WHO) reported that the goose/Guangdong lineage of H5N1 avian influenza viruses caused bird outbreaks in 2020. Also, since 2020, a variant of these viruses belonging to the H5 clade 2.3.4.4b resulted in unprecedented deaths among wild birds and poultry in many European countries. Also, the increase in the trade of animals and animal types in the EU results in spreading of diseases across the region. Therefore, overcoming disease outbreaks from animals is the need of the hour. As a result, the UK promotes high welfare standards for livestock across the EU. Furthermore, the UK is successfully implementing measures such as improving the general well-being of animals to be utilized in scientific testing.
Europe Veterinary Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Europe Veterinary Diagnostics Market Segmentation
The Europe veterinary diagnostics market is segmented based on product, technology, disease type, animal type, end user, and country.
Based on product, the Europe veterinary diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.
By technology, the Europe veterinary diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into lateral flow assays, ELISA, immunoassay, allergen-specific immunodiagnostics test, and other immunodiagnostics. The clinical biochemistry segment is further subsegmented into clinical chemistry analysis, glucose monitoring, and blood gas and electrolyte.
By disease type, the Europe veterinary diagnostics market is segmented into infectious diseases and non-infectious diseases. The infectious diseases segment held the largest share in 2022.
By animal type, the Europe veterinary diagnostics market is bifurcated into livestock animals and companion animals. The companion animals segment held a larger share in 2022. The livestock animals segment is further subsegmented into cattle, pigs, poultry, and other livestock animals. The companion animals segment is further subsegmented into dogs, cats, horses, and other companion animals.
By end user, the Europe veterinary diagnostics market is segmented into veterinary hospitals and clinics, animal diagnostic laboratories, and veterinary research institutes and universities. The companion animals segment held the largest share in 2022.
Based on country, the Europe veterinary diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe veterinary diagnostics market in 2022.
FUJIFILM Holdings Corp, Heska Corp, Idexx Laboratories Inc, INDICAL BIOSCIENCE GmbH, Merck Animal Health, Neogen Corp, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the Europe veterinary diagnostics market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
- 2.2 Europe Veterinary Diagnostics Market, by Country (US$ Million)
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Veterinary Diagnostics Market - Key Industry Dynamics
- 4.1 Key Market Drivers
- 4.1.1 Rising Prevalence of Zoonotic Disease
- 4.1.2 Growing Ownership of Companion Animals
- 4.2 Key Market Restraints
- 4.2.1 Lack of Skilled Professionals in Veterinary Research
- 4.3 Key Market Opportunities
- 4.3.1 Technological Advancements in Veterinary Diagnostics
- 4.4 Future Trends
- 4.4.1 Advent of Precision Medicine in Veterinary Diagnostics
5. Veterinary Diagnostics Market - Europe Market Analysis
- 5.1 Europe Veterinary Diagnostics Market Revenue (US$ Mn), 2022 - 2030
6. Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Product
- 6.1 Overview
- 6.2 Europe Veterinary Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
- 6.3 Instruments
- 6.3.1 Overview
- 6.3.2 Instruments: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Consumables
- 6.4.1 Overview
- 6.4.2 Consumables: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Technology
- 7.1 Overview
- 7.2 Europe Veterinary Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
- 7.3 Immunodiagnostics
- 7.3.1 Overview
- 7.3.2 Immunodiagnostics: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Lateral Flow Assays
- 7.3.3.1 Lateral Flow Assays: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 ELISA Tests
- 7.3.4.1 ELISA Tests: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Immunoassay Analyzers
- 7.3.5.1 Immunoassay Analyzers: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Allergen-Specific Immunodiagnostic Tests
- 7.3.6.1 Allergen-Specific Immunodiagnostic Tests: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Other Immunodiagnostics
- 7.3.7.1 Other Immunodiagnostics: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Clinical Biochemistry
- 7.4.1 Overview
- 7.4.2 Clinical Biochemistry: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Clinical Chemistry Analysis
- 7.4.3.1 Clinical Chemistry Analysis: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Glucose Monitoring
- 7.4.4.1 Glucose Monitoring: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 Blood Gas & Electrolyte
- 7.4.5.1 Blood Gas & Electrolyte: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Hematology
- 7.5.1 Overview
- 7.5.2 Hematology: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6 Molecular Diagnostics
- 7.6.1 Overview
- 7.6.2 Molecular Diagnostics: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.7 Others Veterinary Diagnostic Technologies
- 7.7.1 Overview
- 7.7.2 Others Veterinary Diagnostic Technologies: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Animal Type
- 8.1 Overview
- 8.2 Europe Veterinary Diagnostics Market Revenue Share, by Animal Type 2022 & 2030 (%)
- 8.3 Livestock Animals
- 8.3.1 Overview
- 8.3.2 Livestock Animals: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.3 Cattle
- 8.3.3.1 Cattle: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.4 Pigs
- 8.3.4.1 Pigs: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.5 Poultry
- 8.3.5.1 Poultry: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.6 Other Livestock Animals
- 8.3.6.1 Other Livestock Animals: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Companion Animals
- 8.4.1 Overview
- 8.4.2 Companion Animals: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.3 Dogs
- 8.4.3.1 Dogs: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.4 Cats
- 8.4.4.1 Cats: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.5 Horses
- 8.4.5.1 Horses: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.6 Other Companion Animals
- 8.4.6.1 Other Companion Animals: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Disease Type
- 9.1 Overview
- 9.2 Europe Veterinary Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
- 9.3 Infectious Disease
- 9.3.1 Overview
- 9.3.2 Infectious Disease: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Non-Infectious Disease
- 9.4.1 Overview
- 9.4.2 Non-Infectious Disease: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by End User
- 10.1 Overview
- 10.2 Europe Veterinary Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
- 10.3 Veterinary Hospitals & Clinics
- 10.3.1 Overview
- 10.3.2 Veterinary Hospitals & Clinics: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Animal Diagnostic Laboratories
- 10.4.1 Overview
- 10.4.2 Animal Diagnostic Laboratories: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5 Veterinary Research Institutes & Universities
- 10.5.1 Overview
- 10.5.2 Veterinary Research Institutes & Universities: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis
- 11.1.1 Europe: Veterinary Diagnostics Market, by Country
- 11.1.1.1 Germany: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.1.1 Germany: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.1 Germany: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.2 Germany: Europe Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
- 11.1.3 Germany: Europe Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.3.1 Germany: Europe Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.3.2 Germany: Europe Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
- 11.1.4 Germany: Europe Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.4.1 Germany: Europe Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.4.2 Germany: Europe Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
- 11.1.5 Germany: Europe Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
- 11.1.6 Germany: Europe Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.6.1 France: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.6.1.1 France: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.6.1 France: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.7 France: Europe Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
- 11.1.8 France : Europe Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.8.1 France: Europe Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.8.2 France: Europe Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
- 11.1.9 France: Europe Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.9.1 France: Europe Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.9.2 France: Europe Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
- 11.1.10 France: Europe Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
- 11.1.11 France: Europe Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.11.1 UK: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.11.1.1 UK: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.11.1 UK: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.12 UK: Europe Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
- 11.1.13 UK: Europe Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.13.1 UK: Europe Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.13.2 UK: Europe Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
- 11.1.14 UK: Europe Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.14.1 UK: Europe Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.14.2 UK: Europe Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
- 11.1.15 UK: Europe Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
- 11.1.16 UK: Europe Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.16.1 Italy: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.16.1.1 Italy: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.16.1 Italy: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.17 Italy: Europe Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
- 11.1.18 Italy: Europe Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.18.1 Italy: Europe Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.18.2 Italy: Europe Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
- 11.1.19 Italy: Europe Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.19.1 Italy: Europe Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.19.2 Italy: Europe Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
- 11.1.20 Italy: Europe Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
- 11.1.21 Italy: Europe Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.21.1 Spain: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.21.1.1 Spain: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.21.1 Spain: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.22 Spain: Europe Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
- 11.1.23 Spain: Europe Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.23.1 Spain: Europe Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.23.2 Spain: Europe Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
- 11.1.24 Spain: Europe Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.24.1 Spain: Europe Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.24.2 Spain: Europe Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
- 11.1.25 Spain: Europe Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
- 11.1.26 Spain: Europe Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.26.1 Rest of Europe: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.26.1.1 Rest of Europe: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.26.1 Rest of Europe: Europe Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.27 Rest of Europe: Europe Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
- 11.1.28 Rest of Europe: Europe Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.28.1 Rest of Europe: Europe Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.28.2 Rest of Europe: Europe Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
- 11.1.29 Rest of Europe: Europe Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.29.1 Rest of Europe: Europe Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.29.2 Rest of Europe: Europe Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
- 11.1.30 Rest of Europe: Europe Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
- 11.1.31 Rest of Europe: Europe Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies Done by the Companies in the Market, (%)
- 12.3 Organic Developments
- 12.3.1 Overview
- 12.4 Inorganic Developments
- 12.4.1 Overview
13. Company Profiles
- 13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Idexx Laboratories Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Zoetis Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Heska Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Neogen Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Randox Laboratories Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Virbac SA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 INDICAL BIOSCIENCE GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 FUJIFILM Holdings Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Merck Animal Health
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
